Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,450 | 1,740 | 1,590 | 1,780 | 2,470 |
| TOTAL | $1,450 | $1,740 | $1,590 | $1,780 | $2,470 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 50,780 | 110,080 | 2,670 | 5,390 | 5,630 |
| TOTAL | $50,780 | $110,080 | $2,670 | $5,390 | $5,630 |
| Total Assets | $52,230 | $111,820 | $4,260 | $7,170 | $8,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 700 | 980 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 7,720 | 9,920 | 290 | 750 | 1,050 |
| Accrued Expenses | 0 | 0 | 4,510 | 5,900 | 4,910 |
| Other current liabilities | 620 | 1,530 | 460 | 470 | 520 |
| TOTAL | $9,040 | $12,430 | $6,000 | $7,920 | $7,540 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,640 | 5,450 | 4,410 | 3,080 | 1,670 |
| TOTAL | $6,640 | $5,450 | $4,990 | $4,210 | $3,420 |
| Total Liabilities | $15,680 | $17,880 | $10,990 | $12,130 | $10,960 |
| Shareholders' Equity | |||||
| Common Shares | 50 | 40 | 20 | 20 | 20 |
| Other shareholders' equity | -9,190 | -1,270 | 1,030 | 4,540 | -60 |
| TOTAL | $386,150 | $372,680 | $209,060 | $203,040 | $198,340 |
| Total Liabilities And Equity | $401,830 | $390,560 | $220,050 | $215,170 | $209,300 |